14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for BLPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0553 0.606 %
R2 0.0551 0.259 %
R1 0.0550 0.0442 %
Current price: 0.0550
Support S1 0.0546 -0.650 %
S2 0.0545 -0.86 %
S3 0.0543 -1.21 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0640 16.36 %
R2 0.0571 3.73 %
R1 0.0570 3.64 %
Current price 0.0550
Support S1 0.0535 -2.73%
S2 0.0533 -3.18%
S3 0.0510 -7.27%

BLPH Predictions History

3 years ago
JS predicted that BLPH for 2020-06-30 is going $13.26 (5.66%)

3 years ago
Daniel Clark predicted that BLPH for 2020-06-30 is going $4.70 (-62.55%)

Rank:

3 years ago
EnriqueGonzalez predicted that BLPH for 2020-05-22 is going

Rank:

3 years ago
ZenoxX predicted that BLPH for 2020-05-21 is going

Rank:

3 years ago
JS predicted that BLPH for 2020-05-21 is going $14.69 (6.68%)

3 years ago
Tamisha.Waiters.22376 predicted that BLPH for 2020-05-21 is going

Rank:

3 years ago
JolantaKisielewski predicted that BLPH for 2020-05-21 is going

Rank:

3 years ago
Daniel Clark predicted that BLPH for 2020-05-21 is going $16.00 (15.86%)

Rank:

4 years ago
JS predicted that BLPH for 2020-04-16 is going $12.23 (-3.85%)

4 years ago
brayden edwards predicted that BLPH for 2020-04-16 is going

Rank:
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT